CareLit · DOI-Nachweis · Klinische Neurophysiologie
Intravenous immunoglobulins (IVIG) as long-term therapy in general myasthenia gravis: A case series
DOI 10.1055/s-2008-1072913
Bibliografische Angaben
Nachweis in CareLit
Autor:innenA Wellek, C Eienbröker, B von Hagen, WH Oertel, N Sommer, B Tackenberg
ZeitschriftKlinische Neurophysiologie
Ausgabe04/2008
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: Myasthenia gravis (MG) is an autoimmune disease caused by autoantibodies against acetylcholine receptors at the neuromuscular junction. Steroids and azathioprin are established for long-term immunosuppressive treatment. In cases of failed efficacy other immunosuppressive drugs, like ciclosporine, metho-trexate or mycophenolate can be used. Additionally, IVIG is accepted to be administered in myasthenic…
Zitieren
Zitierempfehlung
A Wellek, C Eienbröker, B von Hagen, WH Oertel, N Sommer, B Tackenberg (2008) Intravenous immunoglobulins (IVIG) as long-term therapy in general myasthenia gravis: A case series. Klinische Neurophysiologie (04). https://doi.org/10.1055/s-2008-1072913
Mit CareLit weiterarbeiten